Literature DB >> 17165668

Selective neck dissection in patients with upper aerodigestive tract cancer with clinically positive nodal disease.

Alfred A Simental1, Umamaheswar Duvvuri, Jonas T Johnson, Eugene N Myers.   

Abstract

OBJECTIVES: We evaluated the efficacy of the application of selective neck dissection to cases of clinically node-positive disease.
METHODS: We performed a retrospective review at the University of Pittsburgh Head and Neck Cancer Database. A database of 65 patients was followed for an average of 36 months (range, 2 to 128 months) after they underwent selective neck dissection for clinically node-positive regional disease.
RESULTS: Regional failure occurred in 8 patients (12.3%). In-field failure was experienced in 4 patients (6.1%), and failures outside the field of dissection occurred in 4 patients (6.1%). The overall incidence of extracapsular spread was 33.8% (22 of 65). Only 2 of 8 regional recurrences were associated with extracapsular spread at the initial neck dissection; however, both recurrences were in the contralateral, undissected side of the neck. Four regional failures were salvaged with surgery, with eventual overall regional control in the neck of 93.9%. Only 1 of 4 ipsilateral recurrences (25%) was successfully salvaged. In contrast, 3 of 4 contralateral failures (75%) were successfully salvaged. In our study population, 21 of 65 cases (32%) that were initially staged as clinically node-positive had no evidence of nodal metastases on pathologic examination.
CONCLUSIONS: The application of selective neck dissection and postoperative irradiation in patients with clinically Nl and limited N2 clinical disease appears to be oncologically efficacious. Clinical overstaging occurred frequently in this sample, and may put patients at risk for more morbid surgical procedures.

Entities:  

Mesh:

Year:  2006        PMID: 17165668     DOI: 10.1177/000348940611501109

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  6 in total

Review 1.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  MR imaging criteria for the prediction of extranodal spread of metastatic cancer in the neck.

Authors:  Y Kimura; M Sumi; N Sakihama; F Tanaka; H Takahashi; T Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

Review 3.  Head and neck cancer.

Authors:  Athanassios Argiris; Michalis V Karamouzis; David Raben; Robert L Ferris
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

Review 4.  Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma.

Authors:  H Hakan Coskun; Jesus E Medina; K Thomas Robbins; Carl E Silver; Primož Strojan; Afshin Teymoortash; Phillip K Pellitteri; Juan P Rodrigo; Sandro J Stoeckli; Ashok R Shaha; Carlos Suárez; Dana M Hartl; Remco de Bree; Robert P Takes; Marc Hamoir; Karen T Pitman; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2014-06-30       Impact factor: 3.147

5.  Bilateral versus ipsilateral neck dissection in oral and oropharyngeal cancer with contralateral cN0 neck.

Authors:  Andreas Knopf; Sven Jacob; Henning Bier; Elias Q Scherer
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-24       Impact factor: 2.503

6.  Selective neck dissection for clinically node-positive oral cavity squamous cell carcinoma.

Authors:  Yoo Seob Shin; Yoon Woo Koh; Se-Heon Kim; Eun Chang Choi
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.